Evidence for calreticulin attenuation of cardiac hypertrophy induced by pressure overload and soluble agonists. - Wikidata - awgldk - TriplyDB

Evidence for calreticulin attenuation of cardiac hypertrophy induced by pressure overload and soluble agonists.

Evidence for calreticulin attenuation of cardiac hypertrophy induced by pressure overload and soluble agonists.

http://www.wikidata.org/entity/Q33703640

about

Adaption of the global test idea to proteomics data with missing values.A novel role for the fifth component of complement (C5) in cardiac physiology.Regulation of microRNA expression in the heart by the ATF6 branch of the ER stress response.Effects of miRNA-455 on cardiac hypertrophy induced by pressure overload.Novel proteins associated with human dilated cardiomyopathy: selective reduction in α(1A)-adrenergic receptors and increased desensitization proteins.Calnexin silencing in mouse neonatal cardiomyocytes induces Ca2+ cycling defects, ER stress, and apoptosis.Calreticulin Is Required for TGF-β-Induced Epithelial-to-Mesenchymal Transition during Cardiogenesis in Mouse Embryonic Stem Cells.Prediction of co-expression genes and integrative analysis of gene microarray and proteomics profile of Keshan disease.

P2860

Q30747017-CAA94346-9967-4FF5-AD93-806E0376A419 Q33988617-7B55F853-2882-4D7C-9EA2-6F9FEC7AD112 Q34253691-48152C57-4AA6-4214-9D38-102AE7DE3F9D Q35167896-F39E9459-98EE-49DA-9CFB-B51DB7B4EC8D Q36761037-14E3FFC0-ED90-48A8-9DD3-424DD5A4F735 Q42269474-811B0585-EDC8-488B-BAAE-5277DAB49253 Q42278306-65ED13DC-EE28-4997-9C30-9F96AA323C24 Q48267415-F93AEC27-8C92-4640-B2E4-8B111B178583

P2860

Evidence for calreticulin attenuation of cardiac hypertrophy induced by pressure overload and soluble agonists.

http://www.wikidata.org/entity/Q33703640

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Evidence for calreticulin atte ...... overload and soluble agonists.

@ast

Evidence for calreticulin atte ...... overload and soluble agonists.

@en

type

label

Evidence for calreticulin atte ...... overload and soluble agonists.

@ast

Evidence for calreticulin atte ...... overload and soluble agonists.

@en

prefLabel

Evidence for calreticulin atte ...... overload and soluble agonists.

@ast

Evidence for calreticulin atte ...... overload and soluble agonists.

@en

P1433

Q33703640-2D0BDA36-70C5-4654-897C-566E79BC37A2

P1476

Q33703640-F28C8956-9385-409E-BBBB-4A8880735879

P2093

Q33703640-1682B2FC-CD95-47FF-8992-B5675B52647E

Q33703640-30FC065B-7381-4B40-9122-DF08E65426B7

Q33703640-742C73AF-F162-4D1B-A849-C4ED9DC8D89B

Q33703640-A2FC41CC-C79D-4D6A-B86D-A11F421FE842

Q33703640-B356C4EC-D603-4912-A1D9-E7CE98274F05

Q33703640-FE261F92-2CF3-498A-9FCA-074ABD3115B4

P2860

Q33703640-01B771E0-2732-4548-9671-AA9C3782D00C

Q33703640-08DEF876-C208-4D4B-B657-223BE4427DD9

Q33703640-1CCCD082-EB9B-4192-BE13-3428D498C408

Q33703640-1D31EDDC-78E7-4E30-8DDC-A8F1B3F2A830

Q33703640-2CD300D8-8DFE-4A0E-88C7-E7BD92B3D33C

Q33703640-3D9773E9-B511-430F-AABC-E74ED5057586

Q33703640-4E5D8D2A-FD0B-4862-8A9E-FE33F99C5EDF

Q33703640-5694AEC3-EE5F-4576-8D77-3C210A10A18B

Q33703640-5BCEDADB-EF78-4E7B-8843-BA57FD19702C

Q33703640-63C13F6F-8675-4A7C-9D77-A02DFE417EAA

P304

Q33703640-AE37F48C-83F5-4AFD-B1A4-82DB0DDEF7C8

P31

Q33703640-F517E5DD-2DE6-427A-B141-FDEB14FAA6F3

P356

Q33703640-58B64D78-7E7F-4063-ACD1-46F431093C9D

P407

Q33703640-A1B1CC83-AAEF-4FA9-82F9-906B37683BFE

P433

Q33703640-E4F6B1AD-5506-4DF8-9409-5C60D8174BE1

P478

Q33703640-C076E0F4-D69B-440F-8FC6-32CFA677DC40

P577

Q33703640-3550FE75-0865-47B2-8523-029E4283D3AE

P5875

Q33703640-8CB86B99-C368-4B47-BF7B-3876342AB67B

P698

Q33703640-55AF5203-418C-45CF-AB69-49D17BB05CD9

P932

Q33703640-D9345654-004D-4C88-A67A-725199AE1515

P356

AJPATH.2010.090392

P1433

The American Journal of Pathology

P1476

Evidence for calreticulin atte ...... overload and soluble agonists.

@en

P2093

Ewa Dziak

http://www.w3.org/2001/XMLSchema#string

Golam Kabir

http://www.w3.org/2001/XMLSchema#string

Michal Opas

http://www.w3.org/2001/XMLSchema#string

Peter Backx

http://www.w3.org/2001/XMLSchema#string

Sophie Clement

http://www.w3.org/2001/XMLSchema#string

Sylvia Papp

http://www.w3.org/2001/XMLSchema#string

P2860

Targeted inhibition of calcineurin prevents agonist-induced cardiomyocyte hypertrophy

The orphan nuclear estrogen receptor-related receptor alpha (ERRalpha) is expressed throughout osteoblast differentiation and regulates bone formation in vitro

Inactivation of focal adhesion kinase in cardiomyocytes promotes eccentric cardiac hypertrophy and fibrosis in mice.

Regulation of cardiac hypertrophy by intracellular signalling pathways

Structures of Src-family tyrosine kinases.

Integrin activation and focal complex formation in cardiac hypertrophy.

Signal transduction and transcriptional adaptation in embryonic heart development and during myocardial hypertrophy.

Signaling pathways for cardiac hypertrophy and failure.

An overview of endothelin signaling in the cardiac myocyte.

Complete heart block and sudden death in mice overexpressing calreticulin.

P304

1113-1121

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2353/AJPATH.2010.090392

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

176

http://www.w3.org/2001/XMLSchema#string

P577

2010-01-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41173714

http://www.w3.org/2001/XMLSchema#string

P698

20110410

http://www.w3.org/2001/XMLSchema#string

P932

2832134

http://www.w3.org/2001/XMLSchema#string